Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

AC Immune (ACIU) Interest & Investment Income (2016 - 2026)

AC Immune has reported Interest & Investment Income over the past 11 years, most recently at $291157.1 for Q1 2026.

  • Quarterly Interest & Investment Income fell 61.9% to $291157.1 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Mar 2026, down 52.62% year-over-year, with the annual reading at $2.3 million for FY2025, 36.04% down from the prior year.
  • Interest & Investment Income was $291157.1 for Q1 2026 at AC Immune, down from $441662.9 in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $1.1 million in Q3 2024 and troughed at -$2.4 million in Q1 2024.
  • The 5-year median for Interest & Investment Income is $322663.5 (2023), against an average of $215393.0.
  • Year-over-year, Interest & Investment Income surged 2732.86% in 2023 and then plummeted 1148.52% in 2024.
  • A 5-year view of Interest & Investment Income shows it stood at $60205.3 in 2022, then surged by 444.9% to $328060.2 in 2023, then surged by 209.34% to $1.0 million in 2024, then plummeted by 56.48% to $441662.9 in 2025, then crashed by 34.08% to $291157.1 in 2026.
  • Per Business Quant, the three most recent readings for ACIU's Interest & Investment Income are $291157.1 (Q1 2026), $441662.9 (Q4 2025), and $457540.1 (Q3 2025).